Warning: The NCBI web site requires JavaScript to function. more...
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.
Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN.
J Autoimmune Dis. 2007 Feb 4;4:2.
Related citations
Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques.
Muratori L, Cataleta M, Muratori P, Manotti P, Lenzi M, Cassani F, Bianchi FB.
J Immunol Methods. 1995 Dec 1;187(2):259-64.
Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection.
Vitozzi S, Lapierre P, Djilali-Saiah I, Marceau G, Beland K, Alvarez F.
Autoimmunity. 2004 May;37(3):217-22.
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K, Rigopoulou E, Dalekos GN.
J Autoimmune Dis. 2004 Oct 15;1(1):2.
Detection on immunoblot of new proteins from the soluble fraction of the cell recognized either by anti-liver-kidney microsome antibodies type 1 or by anti-liver cytosol antibodies type 1--relationship with hepatitis C virus infection.
Ballot E, Desbos A, Monier JC.
Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 1):245-54.
Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.
Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, Bianchi FB.
Gut. 1995 May;36(5):749-54.
Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
Herzog D, Yamamoto AM, Jara P, Maggiore G, Sarles J, Alvarez F.
J Pediatr Gastroenterol Nutr. 1999 Nov;29(5):551-5.
Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN, Zachou K, Liaskos C, Gatselis N.
Eur J Intern Med. 2002 Aug;13(5):293-303.
Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2.
Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, Homberg JC.
Hepatology. 1988 Nov-Dec;8(6):1662-6.
Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
Vitozzi S, Djilali-Saiah I, Lapierre P, Alvarez F.
Autoimmunity. 2002 Dec;35(8):485-92.
Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein.
Vitozzi S, Lapierre P, Djilali-Saiah I, Alvarez F.
J Immunol Methods. 2002 Apr 1;262(1-2):103-10.
Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis.
Muratori L, Cataleta M, Muratori P, Lenzi M, Bianchi FB.
Gut. 1998 May;42(5):721-6.
[Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L, Lu HY, Feng ZR, Yu M, Li WG, Gong WB, Zhao NE, Xu XY.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Aug;23(4):278-81. Chinese.
A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
Hepatogastroenterology. 1997 Mar-Apr;44(14):417-25.
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B, Bogsch F, Klein R, Söhne J, Reichel C, Wasmuth JC, Beuers U, Sauerbruch T, Spengler U.
Eur J Med Res. 2004 Sep 29;9(9):439-48.
Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection.
Béland K, Lapierre P, Marceau G, Alvarez F.
J Autoimmun. 2004 Mar;22(2):159-66.
Autoantibodies and their antigens in autoimmune hepatitis.
Bogdanos DP, Mieli-Vergani G, Vergani D.
Semin Liver Dis. 2009 Aug;29(3):241-53. Epub 2009 Aug 12. Review.
[Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH.
Verh Dtsch Ges Pathol. 1995;79:186-97. Review. German.
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
Ma Y, Gregorio G, Gäken J, Muratori L, Bianchi FB, Mieli-Vergani G, Vergani D.
J Hepatol. 1997 Jun;26(6):1396-402.
[A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE, ter Borg PC, van Buuren HR, Hooijkaas H.
Ned Tijdschr Geneeskd. 2006 Mar 4;150(9):490-4. Dutch.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on